全文获取类型
收费全文 | 30699篇 |
免费 | 791篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 109篇 |
儿科学 | 2100篇 |
妇产科学 | 830篇 |
基础医学 | 1629篇 |
口腔科学 | 506篇 |
临床医学 | 1872篇 |
内科学 | 6900篇 |
皮肤病学 | 333篇 |
神经病学 | 1133篇 |
特种医学 | 810篇 |
外科学 | 5262篇 |
综合类 | 2552篇 |
一般理论 | 1篇 |
预防医学 | 4914篇 |
眼科学 | 467篇 |
药学 | 1319篇 |
8篇 | |
中国医学 | 199篇 |
肿瘤学 | 613篇 |
出版年
2023年 | 175篇 |
2022年 | 364篇 |
2021年 | 663篇 |
2020年 | 485篇 |
2019年 | 3570篇 |
2018年 | 2779篇 |
2017年 | 1310篇 |
2016年 | 309篇 |
2015年 | 350篇 |
2014年 | 1109篇 |
2013年 | 838篇 |
2012年 | 895篇 |
2011年 | 932篇 |
2010年 | 785篇 |
2009年 | 643篇 |
2008年 | 551篇 |
2007年 | 552篇 |
2006年 | 438篇 |
2005年 | 408篇 |
2004年 | 339篇 |
2003年 | 288篇 |
2002年 | 206篇 |
2001年 | 194篇 |
2000年 | 155篇 |
1999年 | 145篇 |
1998年 | 124篇 |
1997年 | 142篇 |
1996年 | 72篇 |
1995年 | 51篇 |
1994年 | 43篇 |
1993年 | 24篇 |
1992年 | 21篇 |
1991年 | 18篇 |
1990年 | 12篇 |
1989年 | 18篇 |
1988年 | 11篇 |
1986年 | 7篇 |
1985年 | 980篇 |
1984年 | 1412篇 |
1983年 | 1054篇 |
1982年 | 1152篇 |
1981年 | 1103篇 |
1980年 | 959篇 |
1979年 | 1061篇 |
1978年 | 990篇 |
1977年 | 689篇 |
1976年 | 886篇 |
1975年 | 787篇 |
1974年 | 701篇 |
1973年 | 736篇 |
排序方式: 共有10000条查询结果,搜索用时 359 毫秒
1.
《Journal of infection and chemotherapy》2022,28(4):548-553
IntroductionCOVID-19 patients have been reported to have digestive symptoms with poor outcome. Ivermectin, an antiparasitic drug, has been used in COVID-19 patients. The objective of this study was to evaluate whether ivermectin has effects on gastrointestinal complications and ventilator-free days in ventilated patients with COVID-19.MethodsCOVID-19 patients who were mechanically ventilated in the ICU were included in this study. The ventilated patients who received ivermectin within 3 days after admission were assigned to the Ivermectin group, and the others were assigned to the Control group. Patients in the Ivermectin group received ivermectin 200 μg/kg via nasal tube. The incidence of gastrointestinal complications and ventilator-free days within 4 weeks from admission were evaluated as clinical outcomes using a propensity score with the inverse probability weighting method.ResultsWe included 88 patients in this study, of whom 39 patients were classified into the Ivermectin group, and 49 patients were classified into the Control group. The hazard ratio for gastrointestinal complications in the Ivermectin group as compared with the Control group was 0.221 (95% confidence interval [CI], 0.057 to 0.855; p = 0.029) in a Cox proportional-hazard regression model. The odds ratio for ventilator-free days as compared with the Control group was 1.920 (95% CI, 1.076 to 3.425; p = 0.027) in a proportional odds logistic regression model.ConclusionsIvermectin improved gastrointestinal complications and the number of ventilator-free days in severe COVID-19 patients undergoing mechanical ventilation. Prevention of gastrointestinal symptoms by SARS-Cov-2 might be associated with COVID-19 outcome. 相似文献
2.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
3.
《Vaccine》2022,40(7):1001-1009
Vaccination guidelines for dogs and cats indicate that core vaccines (for dogs, rabies, distemper, adenovirus, parvovirus; for cats, feline parvovirus, herpes virus-1, calicivirus) are essential to maintain health, and that non-core vaccines be administered according to a clinician’s assessment of a pet’s risk of exposure and susceptibility to infection. A reliance on individual risk assessment introduces the potential for between-practice inconsistencies in non-core vaccine recommendations. A study was initiated to determine non-core vaccination rates of dogs (Leptospira, Borrelia burgdorferi, Bordetella bronchiseptica, canine influenza virus) and cats (feline leukemia virus) in patients current for core vaccines in veterinary practices across the United States. Transactional data for 5,531,866 dogs (1,670 practices) and 1,914,373 cats (1,661 practices) were retrieved from practice management systems for the period November 1, 2016 through January 1, 2020, deidentified and normalized. Non-core vaccination status was evaluated in 2,798,875 dogs and 788,772 cats that were core-vaccine current. Nationally, median clinic vaccination rates for dogs were highest for leptospirosis (70.5%) and B. bronchiseptica (68.7%), and much lower for canine influenza (4.8%). In Lyme-endemic states, the median clinic borreliosis vaccination rate was 51.8%. Feline leukemia median clinic vaccination rates were low for adult cats (34.6%) and for kittens and 1-year old cats (36.8%). Individual clinic vaccination rates ranged from 0 to 100% for leptospirosis, B. bronchiseptica and feline leukemia, 0–96% for canine influenza, and 0–94% for borreliosis. Wide variation in non-core vaccination rates between clinics in similar geographies indicates that factors other than disease risk are driving the use of non-core vaccines in pet dogs and cats, highlighting a need for veterinary practices to address gaps in patient protection. Failure to implement effective non-core vaccination strategies leaves susceptible dogs and cats unprotected against vaccine-preventable diseases. 相似文献
4.
Tonya J.H. White 《Journal of the American Academy of Child and Adolescent Psychiatry》2019,58(11):1042-1050
5.
6.
7.
8.
9.
10.